Herbal hepatotoxicity

被引:140
作者
Stedman, C [1 ]
机构
[1] Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Storr Liver Unit, Westmead, NSW 2145, Australia
[2] Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Dept Clin Pharmacol, Westmead, NSW 2145, Australia
关键词
herbal medicine; Chinese herbal drugs; liver injury; drug-drug interactions;
D O I
10.1055/s-2002-30104
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Herbal hepatotoxicity is increasingly recognized as herbal medicines become more popular in industrialized societies. Some herbal products may potentially benefit people with liver disease; however, these benefits remain generally unproved in humans, and a greater awareness of potential adverse effects is required. Herbal use is often not disclosed, and this may result in a diagnostic delay and perpetuation or exacerbation of liver injury. Female gender may predispose to hepatotoxicity, and concomitant agents that induce cytochrome P450 enzymes may also increase individual susceptibility. The range of liver injury includes minor transaminase elevations, acute and chronic hepatitis, steatosis, cholestasis, zonal or diffuse hepatic necrosis, hepatic fibrosis and cirrhosis, veno-occlusive disease, and acute liver failure requiring transplantation. In addition to the potential for hepatotoxicity, drug-drug interactions between herbal medicines and conventional agents may affect the efficacy and safety of concurrent medical therapy. This review focuses on emerging hepatotoxins and patterns of liver injury, potential risk factors for herbal hepatotoxicity, and herb-drug interactions. Appropriate reporting and regulatory systems to monitor herbal toxicity are required, in conjunction with ongoing scientific evaluation of the potential benefits of phytotherapy.
引用
收藏
页码:195 / 206
页数:12
相关论文
共 92 条
[81]  
Stickel F, 2000, PUBLIC HEALTH NUTR, V3, P113, DOI [10.1017/S1368980000000161, 10.1017/S1368980000000586]
[82]   Necrotizing hepatitis after taking herbal medication (extracts of kava or of common or lesser celandine) [J].
Strahl, S ;
Ehret, V ;
Dahm, HH ;
Maier, KP .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1998, 123 (47) :1410-1414
[83]  
TAKEGOSHI, 1996, BMJ-BRIT MED J, V313, P92
[84]   POSSIBLE HEPATOTOXICITY OF DOXIDAN [J].
TOLMAN, KG ;
HAMMAR, S ;
SANNELLA, JJ .
ANNALS OF INTERNAL MEDICINE, 1976, 84 (03) :290-292
[85]  
Uc A, 2000, SOUTHERN MED J, V93, P596
[86]   Subarachnoid haemorrhage associated with Ginkgo biloba [J].
Vale, S .
LANCET, 1998, 352 (9121) :36-36
[87]   Support of sinusoidal endothelial cell glutathione prevents hepatic veno-occlusive disease in the rat [J].
Wang, XD ;
Kanel, GC ;
DeLeve, LD .
HEPATOLOGY, 2000, 31 (02) :428-434
[88]   ACUTE HEPATITIS ASSOCIATED WITH THE CHINESE HERBAL PRODUCT JIN BU HUAN [J].
WOOLF, GM ;
PETROVIC, LM ;
ROJTER, SE ;
WAINWRIGHT, S ;
VILLAMIL, FG ;
KATKOV, WN ;
MICHIELETTI, P ;
WANLESS, IR ;
STERMITZ, FR ;
BECK, JJ ;
VIERLING, JM .
ANNALS OF INTERNAL MEDICINE, 1994, 121 (10) :729-735
[89]  
WOOLF GM, 1999, HEPATOLOGY A, V550, P1560
[90]  
Yoshida EM, 1996, AM J GASTROENTEROL, V91, P2647